Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Narui, Kazutaka"" wg kryterium: Autor


Tytuł :
Predicting Nonsentinel Lymph Node Metastasis in Breast Cancer: A Multicenter Retrospective Study.
Autorzy :
Mikami Y; Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
Yamada A; Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan. Electronic address: .
Suzuki C; Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
Adachi S; Department of Breast and Thyroid Surgery, Medical Center, Yokohama City University, Yokohama, Kanagawa, Japan.
Harada F; Department of Breast Surgery, Yokohama Rosai Hospital, Yokohama, Kanagawa, Japan.
Yamamoto S; Department of Breast and Thyroid Surgery, Medical Center, Yokohama City University, Yokohama, Kanagawa, Japan.
Shimada K; Department of Breast Surgery, Saiseikai Yokohama-shi Nanbu Hospital, Yokohama, Kanagawa, Japan.
Sugae S; Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
Narui K; Department of Breast and Thyroid Surgery, Medical Center, Yokohama City University, Yokohama, Kanagawa, Japan.
Chishima T; Department of Breast Surgery, Yokohama Rosai Hospital, Yokohama, Kanagawa, Japan.
Ishikawa T; Department of Breast Surgery and Oncology, Tokyo Medical University, Shinjuku-ward, Tokyo, Japan.
Ichikawa Y; Department of Oncology, School of Medicine, Yokohama City University, Yokohama, Kanagawa, Japan.
Endo I; Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, Japan.
Pokaż więcej
Źródło :
The Journal of surgical research [J Surg Res] 2021 Aug; Vol. 264, pp. 45-50. Date of Electronic Publication: 2021 Mar 20.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Bromodomain-containing Protein 4 Is a Favourable Prognostic Factor in Breast Cancer Patients.
Autorzy :
Suzuki C; Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Yamada A; Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan; .
Adachi S; Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Shima H; Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Kida K; Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Oshi M; Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan.; Division of Breast Surgery, Department of Surgical Oncology, Roswell Park Cancer Institute, Buffalo, NY, U.S.A.
Sugae S; Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Yamamoto S; Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, Yokohama, Japan.
Narui K; Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, Yokohama, Japan.
Tanabe M; Division of Diagnostic Pathology, Yokohama City University Medical Center, Yokohama, Japan.
Takabe K; Division of Breast Surgery, Department of Surgical Oncology, Roswell Park Cancer Institute, Buffalo, NY, U.S.A.
Ichikawa Y; Department of Oncology, Yokohama City University Hospital, Yokohama, Japan.
Ishikawa T; Department of Breast Surgery and Oncology, Tokyo Medical University Hospital, Tokyo, Japan.
Endo I; Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Pokaż więcej
Źródło :
Anticancer research [Anticancer Res] 2021 Jul; Vol. 41 (7), pp. 3597-3606.
Typ publikacji :
Journal Article
MeSH Terms :
Breast Neoplasms/*metabolism
Breast Neoplasms/*pathology
Cell Cycle Proteins/*metabolism
Transcription Factors/*metabolism
Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Middle Aged ; Prognosis ; RNA, Messenger/metabolism
Czasopismo naukowe
Tytuł :
Clinical Impact of a Novel Model Predictive of Oncotype DX Recurrence Score in Breast Cancer.
Autorzy :
Yamamoto S; Department of Breast Surgery, Yokohama Rosai Hospital, Yokohama, Japan.; Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, Yokohama, Japan.
Chishima T; Department of Breast Surgery, Yokohama Rosai Hospital, Yokohama, Japan; .
Shibata Y; Department of Breast Surgery, Yokohama Rosai Hospital, Yokohama, Japan.
Harada F; Department of Breast Surgery, Yokohama Rosai Hospital, Yokohama, Japan.
Takeuchi H; Department of Breast Surgery, Yokohama Rosai Hospital, Yokohama, Japan.
Yamada A; Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Narui K; Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, Yokohama, Japan.
Misumi T; Department of Biostatistics, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Ishikawa T; Department of Breast Surgery and Oncology, Tokyo Medical University, Tokyo, Japan.
Endo I; Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Pokaż więcej
Źródło :
In vivo (Athens, Greece) [In Vivo] 2021 Jul-Aug; Vol. 35 (4), pp. 2439-2444.
Typ publikacji :
Journal Article
MeSH Terms :
Breast Neoplasms*/diagnosis
Breast Neoplasms*/genetics
Biomarkers, Tumor/genetics ; Epidermal Growth Factor ; Female ; Gene Expression Profiling ; Humans ; Neoplasm Recurrence, Local/genetics ; Prognosis ; Receptor, ErbB-2/genetics ; Receptors, Estrogen/genetics
Czasopismo naukowe
Tytuł :
Primary breast lymphoma initially diagnosed as invasive ductal carcinoma: A case report.
Autorzy :
Uenaka N; Department of Breast and Thyroid Surgery Yokohama City University Medical Center Yokohama Japan.; Department of Breast Surgery and Oncology Tokyo Medical University Shinjuku-ku Japan.
Yamamoto S; Department of Breast and Thyroid Surgery Yokohama City University Medical Center Yokohama Japan.
Sato S; Department of Breast and Thyroid Surgery Yokohama City University Medical Center Yokohama Japan.
Kudo T; Department of Breast and Thyroid Surgery Yokohama City University Medical Center Yokohama Japan.
Adachi S; Department of Breast and Thyroid Surgery Yokohama City University Medical Center Yokohama Japan.
Narui K; Department of Breast and Thyroid Surgery Yokohama City University Medical Center Yokohama Japan.
Tanabe M; Department of Pathology Yokohama City University Medical Center Yokohama Japan.
Yamada A; Department of Gastroenterological Surgery Yokohama City University Graduate School of Medicine Yokohama Japan.
Ishikawa T; Department of Breast Surgery and Oncology Tokyo Medical University Shinjuku-ku Japan.
Endo I; Department of Gastroenterological Surgery Yokohama City University Graduate School of Medicine Yokohama Japan.
Pokaż więcej
Źródło :
Clinical case reports [Clin Case Rep] 2021 May 05; Vol. 9 (6), pp. e04189. Date of Electronic Publication: 2021 May 05 (Print Publication: 2021).
Typ publikacji :
Case Reports
Raport
Tytuł :
Evaluation of aesthetic outcomes of breast-conserving surgery by the surgeon, nurse, and patients: An analysis.
Autorzy :
Yamamoto S; Department of Breast Surgery, Fujisawa City Hospital, 2-6-1 Fujisawa, Fujisawa City, Kanagawa 251-8550, Japan; Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, 4-57 Urafune-cho, Naka-ku, Yokohama City, Kanagawa, 232-0024, Japan.
Chishima T; Department of Breast Surgery, Yokohama Rosai Hospital, 3211 Kozukue-cho, Kohoku-ku, Yokohama City, Kanagawa, 222-0036, Japan. Electronic address: .
Sugae S; Department of Breast Surgery, Fujisawa City Hospital, 2-6-1 Fujisawa, Fujisawa City, Kanagawa 251-8550, Japan.
Yamagishi S; Department of Breast Surgery, Fujisawa City Hospital, 2-6-1 Fujisawa, Fujisawa City, Kanagawa 251-8550, Japan.
Yamada A; Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama City, Kanagawa, 236-0004, Japan.
Narui K; Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, 4-57 Urafune-cho, Naka-ku, Yokohama City, Kanagawa, 232-0024, Japan.
Misumi T; Department of Biostatistics, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama City, Kanagawa, 236-0004, Japan.
Ishikawa T; Department of Breast Surgery and Oncology, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan.
Endo I; Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama City, Kanagawa, 236-0004, Japan.
Pokaż więcej
Źródło :
Asian journal of surgery [Asian J Surg] 2021 Apr 17. Date of Electronic Publication: 2021 Apr 17.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Prospective cohort study of febrile neutropenia in breast cancer patients administered with neoadjuvant and adjuvant chemotherapies: CSPOR-BC FN study.
Autorzy :
Ishikawa T; Department of Breast Surgery and Oncology, Tokyo Medical University, Tokyo, Japan. Electronic address: .
Sakamaki K; Department of Biostatistics, Yokohama City University, Yokohama, Japan.
Narui K; Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, Yokohama, Japan.
Nishimura H; Department of Breast Surgery, Nagano Municipal Hospital, Nagano, Japan.
Sangai T; Department of Breast and Thyroid Surgery, Chiba University, Chiba, Japan.
Tamaki K; Naha-Nishi Clinic, Okinawa, Japan.
Hasegawa Y; Department of Breast Surgery, Hirosaki Municipal Hospital, Aomori, Japan.
Watanabe KI; Department of Breast Surgery, Hokkaido Cancer Center, Hokkaido, Japan.
Suganuma N; Department of Breast and Thyroid Surgery, Kanagawa Cancer Center, Kanagawa, Japan.
Michishita S; Department of Breast Surgery, Yao Municipal Hospital, Osaka, Japan.
Sugae S; Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Aihara T; Breast Center, Aihara Hospital, Osaka, Japan.
Tsugawa K; Department of Breast and Thyroid Surgery, St. Marianna University, Kawasaki, Japan.
Kaise H; Department of Breast Surgery and Oncology, Tokyo Medical University, Tokyo, Japan.
Taira N; Department of Breast and Endocrinology Surgery, Okayama University Graduate School of Medicine, Okayama, Japan.
Mukai H; Division of Oncology/Hematology, National Cancer Center Hospital East, Chiba, Japan.
Pokaż więcej
Corporate Authors :
for Comprehensive Support Project for Oncological Research of Breast Cancer
Źródło :
Breast (Edinburgh, Scotland) [Breast] 2021 Apr; Vol. 56, pp. 70-77. Date of Electronic Publication: 2021 Feb 16.
Typ publikacji :
Journal Article; Multicenter Study; Observational Study
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*adverse effects
Breast Neoplasms/*drug therapy
Febrile Neutropenia/*chemically induced
Neoadjuvant Therapy/*adverse effects
Adult ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Breast Neoplasms/complications ; Breast Neoplasms/pathology ; Febrile Neutropenia/epidemiology ; Female ; Granulocyte Colony-Stimulating Factor/therapeutic use ; Humans ; In Situ Hybridization, Fluorescence ; Japan ; Middle Aged ; Prospective Studies ; Retrospective Studies ; Risk Factors
Czasopismo naukowe
Tytuł :
First-line Gemcitabine Versus Treatment of Physician's Choice for Metastatic Breast Cancer: A Prospective Cohort Study.
Autorzy :
Yamamoto S; Yokohama City University Medical Center, Department of Breast and Thyroid Surgery, Yokohama, Japan.
Narui K; Yokohama City University Medical Center, Department of Breast and Thyroid Surgery, Yokohama, Japan; .
Ishikawa T; Yokohama City University Medical Center, Department of Breast and Thyroid Surgery, Yokohama, Japan.
Adachi S; Yokohama City University Medical Center, Department of Breast and Thyroid Surgery, Yokohama, Japan.
Shimada K; Yokohama City University Medical Center, Department of Breast and Thyroid Surgery, Yokohama, Japan.
Shimizu D; Yokohama City University Medical Center, Department of Breast and Thyroid Surgery, Yokohama, Japan.
Yamada A; Yokohama City University Graduate School of Medicine, Department of Gastroenterological Surgery, Yokohama, Japan.
Sugae S; Yokohama City University Graduate School of Medicine, Department of Gastroenterological Surgery, Yokohama, Japan.
Tanabe M; Yokohama City University Medical Center, Department of Pathology, Yokohama, Japan.
Oba M; Yokohama City University Medical Center, Department of Biostatics and Epidemiology, Yokohama, Japan.
Morita S; Kyoto University Graduate School of Medicine, Department of Biomedical Statistics and Bioinformatics, Kyoto, Japan.
Doi T; Shonan Kinen Hospital, Breast Center, Kamakura, Japan.
Hasegawa S; Saiseikai Yokohama-shi Nanbu Hospital, Department of Surgery, Yokohama, Japan.
Morita T; Yokosuka Kyosai Hospital, Department of Surgery, Yokosuka, Japan.
Kito A; Yokohama Municipal Citizen's Hospital, Department of Breast Surgery, Yokohama, Japan.
Chishima T; Yokohama Rosai Hospital, Department of Breast Surgery, Yokohama, Japan.
Ichikawa Y; Yokohama City University Graduate School of Medicine, Department of Clinical Oncology, Yokohama, Japan.
Endo I; Yokohama City University Graduate School of Medicine, Department of Gastroenterological Surgery, Yokohama, Japan.
Pokaż więcej
Corporate Authors :
YOKOHAMA CLINCAL ONCOLOGY GROUP
Źródło :
Anticancer research [Anticancer Res] 2021 Mar; Vol. 41 (3), pp. 1671-1676.
Typ publikacji :
Comparative Study; Journal Article; Multicenter Study
MeSH Terms :
Breast Neoplasms/*drug therapy
Deoxycytidine/*analogs & derivatives
Adult ; Aged ; Breast Neoplasms/pathology ; Breast Neoplasms/psychology ; Deoxycytidine/adverse effects ; Deoxycytidine/therapeutic use ; Female ; Humans ; Middle Aged ; Neoplasm Metastasis ; Physicians ; Prospective Studies ; Quality of Life ; Treatment Failure
Czasopismo naukowe
Tytuł :
Impact of the Relative Dose Intensity of Neoadjuvant Chemotherapy With Anthracycline Followed by Taxane on the Survival of Patients With Human Epidermal Growth Factor Receptor 2-negative Breast Cancer: The JONIE1 Study.
Autorzy :
Yamada A; Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Nakazawa K; Department of Medical Informatics, Niigata University Medical and Dental Hospital, Niigata, Japan.
Akazawa K; Department of Medical Informatics, Niigata University Medical and Dental Hospital, Niigata, Japan.
Narui K; Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, Yokohama, Japan.
Endo I; Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Hasegawa Y; Department of Breast Surgery, Hirosaki Municipal Hospital, Hirosaki, Japan.
Kohno N; Department of Breast Surgery, Kobe Kaisei Hospital, Kobe, Japan.
Ishikawa T; Department of Breast Oncology and Surgery, Tokyo Medical University, Tokyo, Japan .
Pokaż więcej
Corporate Authors :
JONIE STUDY GROUP
Źródło :
Anticancer research [Anticancer Res] 2021 Feb; Vol. 41 (2), pp. 1063-1068.
Typ publikacji :
Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial
MeSH Terms :
Anthracyclines/*administration & dosage
Antineoplastic Combined Chemotherapy Protocols/*administration & dosage
Breast Neoplasms/*drug therapy
Paclitaxel/*administration & dosage
Receptor, ErbB-2/*metabolism
Adult ; Aged ; Anthracyclines/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Breast Neoplasms/metabolism ; Breast Neoplasms/mortality ; Drug Administration Schedule ; Drug Dosage Calculations ; Female ; Humans ; Middle Aged ; Neoadjuvant Therapy ; Paclitaxel/therapeutic use ; Survival Analysis ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Efficacy of the eribulin, pertuzumab, and trastuzumab combination therapy for human epidermal growth factor receptor 2-positive advanced or metastatic breast cancer: a multicenter, single arm, phase II study (JBCRG-M03 study).
Autorzy :
Yamashita T; Department of Breast and Endocrine Surgery, Kanagawa Cancer Center, 2-3-2 Nakao, Asahi-ku, Yokohama, 241-8515, Japan. .
Kawaguchi H; Department of Breast Surgery, Matsuyama Red Cross Hospital, Matsuyama, Japan.
Masuda N; Department of Surgery, Breast Oncology, NHO Osaka National Hospital, Osaka, Japan.
Kitada M; Breast Disease Center, Asahikawa Medical University Hospital, Asahikawa, Japan.
Narui K; Breast and Thyroid Surgery, Yokohama City University Medical Center, Yokohama, Japan.
Hattori M; Department of Breast Oncology, Aichi Cancer Center, Nagoya, Japan.
Yoshinami T; Department of Medical Oncology, Osaka International Cancer Institute, Osaka, Japan.
Matsunami N; Department of Breast Surgery, Osaka Rosai Hospital, Sakai, Japan.
Yanagihara K; Department of Medical Oncology, Kansai Electric Power Hospital, Osaka, Japan.
Kawasoe T; Department of Breast and Endocrine Surgery, Japanese Red Cross Kumamoto Hospital, Kumamoto, Japan.
Nagashima T; Department of General Surgery, Chiba University Hospital, Chiba, Japan.
Bando H; Breast and Endocrine Surgery, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Yano H; Department of Surgery, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Hasegawa Y; Department of Breast Surgery, Hirosaki Municipal Hospital, Hirosaki, Japan.
Nakamura R; Department of Breast Surgery, Chiba Cancer Center, Chiba, Japan.
Kashiwaba M; Breast Surgery, Sagara Hospital, Kagoshima, Japan.
Morita S; Department of Biomedical Statistics and Bioinformatics, Graduate School of Medicine Kyoto University, Kyoto, Japan.
Ohno S; Center of Breast Oncology, The Cancer Institute Hospital of JFCR, Tokyo, Japan.
Toi M; Department of Surgery (Breast Surgery), Graduate School of Medicine Kyoto University, Kyoto, Japan.
Pokaż więcej
Źródło :
Investigational new drugs [Invest New Drugs] 2021 Feb; Vol. 39 (1), pp. 217-225. Date of Electronic Publication: 2020 Aug 24.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Aldehyde Dehydrogenase 1-related Genes in Triple-negative Breast Cancer Investigated Using Network Analysis.
Autorzy :
Yamada A; Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Kanagawa, Japan; .
Suzuki C; Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.
Shima H; Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.
Kida K; Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, Kanagawa, Japan.
Adachi S; Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, Kanagawa, Japan.
Yamamoto S; Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, Kanagawa, Japan.
Narui K; Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, Kanagawa, Japan.
Tanabe M; Department of Pathology, Yokohama City University Medical Center, Kanagawa, Japan.
Shimizu D; Department of Breast Surgery, Yokohama City Minato Red Cross Hospital, Kanagawa, Japan.
Taniguchi R; KM data Inc., Tokyo, Japan.
Oshi M; Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.; Division of Breast Surgery, Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, U.S.A.
Takabe K; Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.; Division of Breast Surgery, Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, U.S.A.; Department of Breast Disease, Tokyo Medical University Hospital, Tokyo, Japan.
Miyagi Y; Molecular Pathology and Genetics Division, Kanagawa Cancer Center Research Institute, Kanagawa, Japan.
Ichikawa Y; Department of Oncology, Yokohama City University, Kanagawa, Japan.
Ishikawa T; Department of Breast Disease, Tokyo Medical University Hospital, Tokyo, Japan.
Endo I; Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Kanagawa, Japan.
Pokaż więcej
Źródło :
Anticancer research [Anticancer Res] 2020 Dec; Vol. 40 (12), pp. 6733-6742.
Typ publikacji :
Journal Article
MeSH Terms :
Gene Regulatory Networks*
Genes, Neoplasm*
Aldehyde Dehydrogenase/*metabolism
Triple Negative Breast Neoplasms/*enzymology
Triple Negative Breast Neoplasms/*genetics
Cohort Studies ; Down-Regulation/genetics ; Female ; Gene Expression Regulation, Neoplastic ; Gene Ontology ; Humans ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Signal Transduction ; Triple Negative Breast Neoplasms/pathology ; Up-Regulation/genetics
Czasopismo naukowe
Tytuł :
Prediction of pathological complete response after neoadjuvant chemotherapy in breast cancer by combining magnetic resonance imaging and core needle biopsy.
Autorzy :
Narui K; Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, Yokohama, Japan.
Ishikawa T; Department of Breast Oncology and Surgery, Tokyo Medical University, Tokyo, Japan. Electronic address: .
Oba MS; Department of Medical Statistics, Toho University, Tokyo, Japan.
Hasegawa Y; Department of Breast Surgery, Hirosaki Municipal Hospital, Hirosaki, Japan.
Kaise H; Department of Breast Oncology and Surgery, Tokyo Medical University, Tokyo, Japan.
Kawate T; Department of Breast Oncology and Surgery, Tokyo Medical University, Tokyo, Japan.
Yamada A; Department of Gastroenterological Surgery, Yokohama City University, Yokohama, Japan.
Yamada K; Department of Breast Oncology and Surgery, Tokyo Medical University, Tokyo, Japan.
Suzuki Y; Department of Breast and Endocrine Surgery, Tokai University School of Medicine, Isehara, Japan.
Niikura N; Department of Breast and Endocrine Surgery, Tokai University School of Medicine, Isehara, Japan.
Kohno N; Department of Breast Surgery, Kobe Kaisei Hospital, Kobe, Japan.
Kimoto T; Department of Breast Surgery, Kobe Kaisei Hospital, Kobe, Japan.
Sugae S; Department of Gastroenterological Surgery, Yokohama City University, Yokohama, Japan.
Kosaka Y; Department of Breast and Endocrine Surgery, Kitasato University School of Medicine, Sagamihara, Japan.
Miyashita M; Department of Surgery, Konan Hospital, Kobe, Japan.
Okamura T; Department of Breast and Endocrine Surgery, Tokai University School of Medicine, Isehara, Japan.
Shimizu D; Department of Breast Surgery, Yokohama City Minato Red Cross Hospital, Yokohama, Japan.
Tanino H; Department of Breast and Endocrine Surgery, Kitasato University School of Medicine, Sagamihara, Japan.
Tanabe M; Division of Diagnostic Pathology, Yokohama City University Medical Center, Yokohama, Japan.
Morita S; Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Endo I; Department of Gastroenterological Surgery, Yokohama City University, Yokohama, Japan.
Tokuda Y; Department of Breast and Endocrine Surgery, Tokai University School of Medicine, Isehara, Japan.
Pokaż więcej
Źródło :
Surgical oncology [Surg Oncol] 2020 Dec; Vol. 35, pp. 447-452. Date of Electronic Publication: 2020 Oct 06.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Development of an invasive ductal carcinoma in a contralateral composite nipple graft after an autologous breast reconstruction: a case report.
Autorzy :
Kimura M; Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama, 232-0024, Japan. .; Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan. .
Narui K; Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama, 232-0024, Japan.
Shima H; Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama, 232-0024, Japan.
Ikejima S; Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama, 232-0024, Japan.
Muto M; Plastic and Reconstructive Surgery, Yokohama City University Medical Center, Yokohama, Japan.
Satake T; Plastic and Reconstructive Surgery, Yokohama City University Medical Center, Yokohama, Japan.
Tanabe M; Diagnostic Pathology, Yokohama City University Medical Center, Yokohama, Japan.
Inayama Y; Diagnostic Pathology, Yokohama City University Medical Center, Yokohama, Japan.
Adachi S; Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama, 232-0024, Japan.
Yamada A; Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama, 232-0024, Japan.
Shimada K; Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, 4-57 Urafune-cho, Minami-ku, Yokohama, 232-0024, Japan.
Sugae S; Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Ichikawa Y; Department of Oncology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Ishikawa T; Department of Breast Oncology and Surgery, Tokyo Medical University, Shinjuku, Tokyo, Japan.
Endo I; Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Pokaż więcej
Źródło :
Surgical case reports [Surg Case Rep] 2020 Aug 08; Vol. 6 (1), pp. 203. Date of Electronic Publication: 2020 Aug 08.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Long-Term Outcomes of Immediate Autologous Breast Reconstruction for Breast Cancer Patients.
Autorzy :
Yamada A; Department of Gastroenterological Surgery, Yokohama City University School of Medicine, Kanazawa, Yokohama, Kanagawa, Japan; Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, Minami, Yokohama, Kanagawa, Japan.
Narui K; Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, Minami, Yokohama, Kanagawa, Japan. Electronic address: .
Satake T; Department of Plastic Surgery, Yokohama City University Medical Center, Minami, Yokohama, Kanagawa, Japan.
Adachi S; Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, Minami, Yokohama, Kanagawa, Japan.
Tanabe M; Department of Pathology, Yokohama City University Medical Center, Minami, Yokohama, Kanagawa, Japan.
Shimizu D; Department of Breast Surgery, Yokohama City Minato Red Cross Hospital, Naka, Yokohama, Kanagawa, Japan.
Ishikawa T; Department of Breast Surgery and Oncology, Tokyo Medical University, Shinjuku, Tokyo, Japan.
Endo I; Department of Gastroenterological Surgery, Yokohama City University School of Medicine, Kanazawa, Yokohama, Kanagawa, Japan.
Pokaż więcej
Źródło :
The Journal of surgical research [J Surg Res] 2020 Jul; Vol. 251, pp. 78-84. Date of Electronic Publication: 2020 Feb 26.
Typ publikacji :
Journal Article
MeSH Terms :
Mastectomy, Subcutaneous*
Breast Neoplasms/*surgery
Carcinoma, Intraductal, Noninfiltrating/*surgery
Mammaplasty/*methods
Adult ; Aged ; Female ; Humans ; Middle Aged ; Retrospective Studies ; Transplantation, Autologous ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
Neoadjuvant Chemotherapy With Anthracycline-Based Regimen for BRCAness Tumors in Triple-Negative Breast Cancer.
Autorzy :
Teraoka S; Department of Breast Oncology and Surgery, Tokyo Medical University, Shinjuku-ku, Tokyo, Japan.
Sato E; Department of Pathology, Tokyo Medical University, Shinjuku-ku, Tokyo, Japan.
Narui K; Department of Breast Surgery, Yokohama City University Medical Center, Yokohama-shi, Kanagawa, Japan.
Yamada A; Department of Breast Surgery, Chigasaki Medical Hospital, Chigasaki-shi, Kanagawa, Japan.
Fujita T; Department of Breast and Thyroid Surgery, Tokyo Medical University Ibaraki Medical Center, Inashikigun, Ibaraki, Japan.
Yamada K; Department of Breast Oncology and Surgery, Tokyo Medical University, Shinjuku-ku, Tokyo, Japan.
Oba M; Department of Medical Statistics, Faculty of Medicine, Toho University, Ota-ku, Tokyo, Japan.
Ishikawa T; Department of Breast Oncology and Surgery, Tokyo Medical University, Shinjuku-ku, Tokyo, Japan. Electronic address: .
Pokaż więcej
Źródło :
The Journal of surgical research [J Surg Res] 2020 Jun; Vol. 250, pp. 143-147. Date of Electronic Publication: 2020 Feb 07.
Typ publikacji :
Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Anthracyclines/*therapeutic use
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
BRCA1 Protein/*metabolism
Neoadjuvant Therapy/*methods
Triple Negative Breast Neoplasms/*therapy
Adult ; Aged ; BRCA1 Protein/analysis ; Chemotherapy, Adjuvant/methods ; Cyclophosphamide/therapeutic use ; Docetaxel/therapeutic use ; Epirubicin/therapeutic use ; Female ; Fluorouracil/therapeutic use ; Humans ; Mastectomy ; Middle Aged ; Pilot Projects ; Prospective Studies ; Treatment Outcome ; Triple Negative Breast Neoplasms/pathology
SCR Protocol :
FEC protocol
Czasopismo naukowe
Tytuł :
Immediate Breast Reconstruction with a Deep Inferior Epigastric Perforator Flap in the Lithotomy Position.
Autorzy :
Tamura S; Department of Plastic and Reconstructive Surgery, Yokohama City University Medical Center, Yokohama, Kanagawa, Japan.
Satake T; Department of Plastic and Reconstructive Surgery, Yokohama City University Medical Center, Yokohama, Kanagawa, Japan.
Muto M; Department of Plastic and Reconstructive Surgery, Yokohama City University Medical Center, Yokohama, Kanagawa, Japan.
Shibuya M; Department of Plastic and Reconstructive Surgery, Yokohama City University Medical Center, Yokohama, Kanagawa, Japan.
Narui K; Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, Yokohama, Kanagawa, Japan.
Kobayashi S; Department of Plastic and Reconstructive Surgery, Kanagawa Children's Medical Center, Yokohama, Kanagawa, Japan.
Ishikawa T; Department of Breast Oncology and Surgery, Tokyo Medical University Hospital, Shinjuku, Tokyo, Japan.
Maegawa J; Department of Plastic and Reconstructive Surgery, Yokohama City University Hospital, Yokohama, Kanagawa, Japan.
Pokaż więcej
Źródło :
Plastic and reconstructive surgery. Global open [Plast Reconstr Surg Glob Open] 2019 Dec 26; Vol. 7 (12), pp. e2552. Date of Electronic Publication: 2019 Dec 26 (Print Publication: 2019).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Clinical and pathological predictors of recurrence in breast cancer patients achieving pathological complete response to neoadjuvant chemotherapy.
Autorzy :
Asaoka M; Department of Breast Oncology and Surgery, Tokyo Medical University Hospital, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan; Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Elm & Carlton Streets, Buffalo, NY, 14263, USA.
Narui K; Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, 4-57 Urafune, Minami-ku, Yokohama, Kanagawa, 232-0024, Japan.
Suganuma N; Department of Mammary Gland Endocrine Surgery, Kanagawa Cancer Center, 2-3-2 Nakano, Asahi-ku, Yokohama, Kanagawa, 241-8515, Japan.
Chishima T; Department of Breast Surgery, Yokohama Rosai Hospital, 3211 Kozukue-Chō, Kōhoku-Ku, Yokohama, Kanagawa, 222-0036, Japan.
Yamada A; Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, 4-57 Urafune, Minami-ku, Yokohama, Kanagawa, 232-0024, Japan; Department of Gastroenterological Surgery, Yokohama City University, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan.
Sugae S; Department of Gastroenterological Surgery, Yokohama City University, 3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan.
Kawai S; Department of Breast Oncology and Surgery, Tokyo Medical University Hospital, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan.
Uenaka N; Department of Breast Oncology and Surgery, Tokyo Medical University Hospital, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan.
Teraoka S; Department of Breast Oncology and Surgery, Tokyo Medical University Hospital, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan.
Miyahara K; Department of Breast Oncology and Surgery, Tokyo Medical University Hospital, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan.
Kawate T; Department of Breast Oncology and Surgery, Tokyo Medical University Hospital, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan.
Sato E; Department of Pathology, Institute of Medical Science (Medical Research Center, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan.
Nagao T; Department of Pathology, Institute of Medical Science (Medical Research Center, Tokyo Medical University, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan.
Matsubara Y; Department of Mammary Gland Endocrine Surgery, Kanagawa Cancer Center, 2-3-2 Nakano, Asahi-ku, Yokohama, Kanagawa, 241-8515, Japan.
Gandhi S; Division of Breast Medicine, Department of Medicine, Roswell Park Comprehensive Cancer Center, Elm & Carlton Streets, Buffalo, NY, 14263, USA.
Takabe K; Department of Breast Oncology and Surgery, Tokyo Medical University Hospital, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan; Department of Surgical Oncology, Roswell Park Comprehensive Cancer Center, Elm & Carlton Streets, Buffalo, NY, 14263, USA.
Ishikawa T; Department of Breast Oncology and Surgery, Tokyo Medical University Hospital, 6-7-1 Nishishinjuku, Shinjuku-ku, Tokyo, 160-0023, Japan. Electronic address: .
Pokaż więcej
Źródło :
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2019 Dec; Vol. 45 (12), pp. 2289-2294. Date of Electronic Publication: 2019 Aug 02.
Typ publikacji :
Journal Article; Multicenter Study
MeSH Terms :
Chemotherapy, Adjuvant*
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Breast Neoplasms/*drug therapy
Neoplasm Recurrence, Local/*pathology
Adult ; Aged ; Biopsy ; Breast Neoplasms/pathology ; Breast Neoplasms/surgery ; Disease-Free Survival ; Female ; Follow-Up Studies ; Humans ; Japan ; Middle Aged ; Neoadjuvant Therapy ; Neoplasm Metastasis ; Neoplasm Staging ; Prognosis ; Receptor, ErbB-2 ; Retrospective Studies ; Tumor Burden
Czasopismo naukowe
Tytuł :
Anthracycline could be essential for triple-negative breast cancer: A randomised phase II study by the Kanagawa Breast Oncology Group (KBOG) 1101.
Autorzy :
Narui K; Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, Yokohama, Japan. Electronic address: .
Ishikawa T; Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, Yokohama, Japan; Department of Breast Oncology and Surgery, Tokyo Medical University, Tokyo, Japan. Electronic address: .
Shimizu D; Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, Yokohama, Japan. Electronic address: .
Yamada A; Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, Yokohama, Japan. Electronic address: .
Tanabe M; Division of Diagnostic Pathology, Yokohama City University Medical Center, Yokohama, Japan. Electronic address: .
Sasaki T; Division of Diagnostic Pathology, Yokohama City University Medical Center, Yokohama, Japan. Electronic address: .
Oba MS; Department of Biostatistics and Epidemiology, Yokohama City University Medical Center, Yokohama, Japan. Electronic address: .
Morita S; Department of Biostatistics and Epidemiology, Yokohama City University Medical Center, Yokohama, Japan. Electronic address: .
Nawata S; Pharmaceutical Department, Yokohama City University Medical Center, Yokohama, Japan. Electronic address: .
Kida K; Department of Breast and Thyroid Surgery, Yokohama City University Medical Center, Yokohama, Japan. Electronic address: .
Mogaki M; Department of Surgery, Yokosuka Kyosai Hospital, Yokosuka, Japan. Electronic address: .
Doi T; Kamakura Breast Cancer Center, Shonan Memorial Hospital, Kamakura, Japan. Electronic address: .
Tsugawa K; Department of Breast and Endocrine Surgery, St. Marianna University School of Medicine, Kawasaki, Japan. Electronic address: .
Ogata H; Department of Breast and Endocrine Surgery, St. Marianna University School of Medicine, Kawasaki, Japan. Electronic address: .
Ota T; Department of Translational Oncology, St. Marianna University School of Medicine, Kawasaki, Japan. Electronic address: .
Kosaka Y; Department of Breast and Endocrine Surgery, Kitasato University Hospital, Sagamihara, Japan. Electronic address: .
Sengoku N; Department of Breast and Endocrine Surgery, Kitasato University Hospital, Sagamihara, Japan. Electronic address: .
Kuranami M; Department of Breast and Endocrine Surgery, Kitasato University Hospital, Sagamihara, Japan. Electronic address: .
Niikura N; Department of Breast and Endocrine Surgery, Tokai University School of Medicine, Isehara, Japan. Electronic address: .
Saito Y; Department of Breast and Endocrine Surgery, Tokai University School of Medicine, Isehara, Japan. Electronic address: .
Suzuki Y; Department of Breast and Endocrine Surgery, Tokai University School of Medicine, Isehara, Japan. Electronic address: .
Suto A; Department of Breast and Endocrine Surgery, St. Marianna University School of Medicine, Kawasaki, Japan. Electronic address: .
Arioka H; Department of Medical Oncology, Yokohama Rosai Hospital, Yokohama, Japan. Electronic address: .
Chishima T; Department of Oncology, Yokohama City University, Yokohama, Japan. Electronic address: .
Ichikawa Y; Department of Oncology, Yokohama City University, Yokohama, Japan. Electronic address: .
Endo I; Department of Gastroenterological Surgery, Yokohama City University, Yokohama, Japan. Electronic address: .
Tokuda Y; Department of Translational Oncology, St. Marianna University School of Medicine, Kawasaki, Japan. Electronic address: .
Pokaż więcej
Źródło :
Breast (Edinburgh, Scotland) [Breast] 2019 Oct; Vol. 47, pp. 1-9. Date of Electronic Publication: 2019 Jun 15.
Typ publikacji :
Clinical Trial, Phase II; Comparative Study; Journal Article; Randomized Controlled Trial
MeSH Terms :
Anthracyclines/*therapeutic use
Breast Neoplasms/*drug therapy
Docetaxel/*therapeutic use
Fluorouracil/*therapeutic use
Triple Negative Breast Neoplasms/*drug therapy
Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Breast Neoplasms/diagnosis ; Breast Neoplasms/mortality ; Breast Neoplasms/surgery ; Chemotherapy, Adjuvant ; Cyclophosphamide/therapeutic use ; Disease-Free Survival ; Dose-Response Relationship, Drug ; Drug Administration Schedule ; Epirubicin/therapeutic use ; Female ; Humans ; Japan ; Kaplan-Meier Estimate ; Mastectomy, Segmental/methods ; Middle Aged ; Prognosis ; Prospective Studies ; Risk Assessment ; Statistics, Nonparametric ; Survival Analysis ; Treatment Outcome ; Triple Negative Breast Neoplasms/diagnosis ; Triple Negative Breast Neoplasms/mortality ; Triple Negative Breast Neoplasms/surgery
SCR Protocol :
FEC protocol
Czasopismo naukowe
Tytuł :
Risk Analysis for Chemotherapy-induced Nausea and Vomiting (CINV) in Patients Receiving FEC100 Treatment.
Autorzy :
Hayashi M; Breast Center, Dokkyo Medical University, Tochigi, Japan .
Nakazawa K; Department of Medical Informatics, Niigata University, Niigata, Japan.
Hasegawa Y; Department of Breast Surgery, Hirosaki Municipal Hospital, Hirosaki, Japan.
Horiguchi J; Department of Breast Surgery, International University of Health and Welfare, Chiba, Japan.
Miura D; Akasaka Miura Clinic, Tokyo, Japan.
Ishikawa T; Department of Breast Oncology, Tokyo Medical University, Tokyo, Japan.
Takao S; Department of Breast Surgery, Hyogo Cancer Center, Hyogo, Japan.
Kim SJ; Department of Breast and Endocrine Surgery, Osaka University, Osaka, Japan.
Yamagami K; Department of Breast Oncology, Shinko Hospital, Hyogo, Japan.
Miyashita M; Department of Surgery, Kohnan Hospital, Hyogo, Japan.
Konishi M; Department of Surgery, Hyogo Prefectural Nishinomiya Hospital, Hyogo, Japan.
Shigeoka Y; Department of Medical Oncology, Yodogawa Christian Hospital, Osaka, Japan.
Suzuki M; Department of Surgery, National Hospital Organization Chiba Medical Center, Chiba, Japan.
Taguchi T; Department of Endocrine and Breast Surgery, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Kubota T; Department of Surgery, Kamiiida Daiichi General Hospital, Aichi, Japan.
Tanino H; Department of Surgery, Kobe University, Hyogo, Japan.
Yamada K; Department of Breast Oncology, Hachioji Medical Center, Tokyo Medical University, Tokyo, Japan.
Narui K; Department of Breast and Endocrine Surgery, Yokohama City University Medical Center, Kanagawa, Japan.
Kimura K; Department of Medical Informatics, Niigata University, Niigata, Japan.
Akazawa K; Department of Medical Informatics, Niigata University, Niigata, Japan.
Kohno N; Department of Breast Surgery, Kobe Kaisei Hospital, Hyogo, Japan.
Pokaż więcej
Corporate Authors :
JONIE STUDY GROUP
Źródło :
Anticancer research [Anticancer Res] 2019 Aug; Vol. 39 (8), pp. 4305-4314.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Antineoplastic Agents/*adverse effects
Breast Neoplasms/*drug therapy
Nausea/*epidemiology
Vomiting/*epidemiology
Adult ; Age Factors ; Aged ; Breast Neoplasms/complications ; Breast Neoplasms/epidemiology ; Breast Neoplasms/pathology ; Drug Therapy, Combination/adverse effects ; Female ; Humans ; Induction Chemotherapy/adverse effects ; Middle Aged ; Nausea/chemically induced ; Nausea/pathology ; Risk Factors ; Vomiting/chemically induced ; Vomiting/pathology
Czasopismo naukowe
Tytuł :
Efficacy of denosumab for restoring normal bone mineral density in women receiving adjuvant aromatase inhibitors for early breast cancer.
Autorzy :
Sakaguchi K; Division of Endocrine and Breast Surgery, Kyoto Prefectural University of Medicine, Kawaramachi-hirokoji, Kamigyo-ku, Kyoto.
Ono H; Division of Endocrine and Breast Surgery, Kyoto Prefectural University of Medicine, Kawaramachi-hirokoji, Kamigyo-ku, Kyoto.; Drug Discovery Center, Graduate School of Medicine.
Nakatsukasa K; Department of Biostatistics, Graduate School of Medicine, Hokkaido University, Nakatsukasa Adachi Clinic, Japan.
Ishikawa T; Department of Biostatistics, Kyoto Prefectural University of Medicine Graduate School of Medical Science.
Hasegawa Y; Department of Radiology, Tokyo Medical University.
Takahashi M; Department of Breast Surgical Oncology, Hirosaki Municipal Hospital.
Niikura N; Department of Breast Surgery, Hokkaido Cancer Center.
Koizumi K; Department of Breast and Endocrine Surgery, Tokai University School of Medicine.
Sakurai T; Department of Breast Surgery, Hamamatsu University School of Medicine.
Shigematsu H; Department of Surgery, Wakayama Medical University Kihoku Hospital.
Takahashi S; Department of Breast Surgery, National Hospital Organization Kure Medical Center and Chugoku Cancer Center.
Taira S; Department of Breast Surgery, National Hospital Organization Kure Medical Center and Chugoku Cancer Center.
Suzuki M; Department of Medical Oncology, Cancer Institute Hospital of Japanese Foundation for Cancer Research.
Narui K; Department of Breast Surgery, National Hospital Organization Chiba Medical Center, Yokohama City University Medical Center.
Miura D; Department of Breast and Thyroid Surgery, Yokohama City University Medical Center.
Yamada K; Department of Biostatistics, Kyoto Prefectural University of Medicine Graduate School of Medical Science.
Yoshimura M; Department of Breast Oncology.
Shioya H; Akasaka Miura Clinic, Tokyo.
Konishi E; Department of Surgical Pathology, Kyoto Prefectural University of Medicine.
Isao Y; Department of Surgery, The Jikei University School of Medicine.
Imai K; Department for Medical Innovation and Translational Medical Science.
Fujikawa K; Kyoto Prefectural University of Medicine Graduate School of Medical Science.
Taguchi T; Division of Endocrine and Breast Surgery, Kyoto Prefectural University of Medicine, Kawaramachi-hirokoji, Kamigyo-ku, Kyoto.
Pokaż więcej
Corporate Authors :
Collaborative Study Group of Scientific Research of the Japanese Breast Cancer Society
Źródło :
Medicine [Medicine (Baltimore)] 2019 Aug; Vol. 98 (32), pp. e16770.
Typ publikacji :
Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms :
Aromatase Inhibitors/*adverse effects
Bone Density/*drug effects
Denosumab/*administration & dosage
Osteoporosis/*chemically induced
Osteoporosis/*prevention & control
Adult ; Aromatase Inhibitors/therapeutic use ; Biomarkers ; Bone and Bones/metabolism ; Breast Neoplasms/drug therapy ; Disease-Free Survival ; Female ; Fractures, Bone/epidemiology ; Humans ; Middle Aged ; Neoplasm Staging ; Research Design
Czasopismo naukowe
Tytuł :
Participants in a randomized controlled trial had longer overall survival than non-participants: a prospective cohort study.
Autorzy :
Ohno S; Breast Oncology Center, Cancer Institute Hospital, Tokyo, Japan.
Mukai H; Division of Breast and Medical Oncology, National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa, Japan. .
Narui K; Breast and Thyroid Surgery, Yokohama City University Medical Center, Yokohama, Japan.
Hozumi Y; Department of Breast and Endocrine Surgery, University of Tsukuba Hospital, Tsukuba, Japan.; Department of Breast Surgery, Ibaraki Prefectural Central Hospital, Tsukuba, Japan.
Miyoshi Y; Department of Breast and Endocrine Surgery, Hyogo College of Medicine, Nishinomiya, Japan.
Yoshino H; Gastrointestinal Surgery and Breast and Endocrinological Surgery, Ishikawa Prefectural Central Hospital, Kanazawa, Japan.
Doihara H; Breast and Endocrine Surgery, Okayama University Hospital, Okayama, Japan.
Suto A; Department of Breast Surgery, Yamato Municipal Hospital, Yamato, Japan.
Tamura M; Department of Surgery and Pathology, KKR Sapporo Medical Center, Sapporo, Japan.
Morimoto T; Department of Breast Surgery, Yao Municipal Hospital, Yao, Japan.
Zaha H; Department of Breast Surgery, Nakagami Hospital, Okinawa, Japan.
Chishima T; Department of Breast Surgery, Yokohama Rosai Hospital, Yokohama, Japan.
Nishimura R; Department of Breast Oncology, Kumamoto Shinto General Hospital, Kumamoto, Japan.
Ishikawa T; Department of Breast Surgery, Tokyo Medical University, Tokyo, Japan.
Uemura Y; Biostatistics Division, Clinical Research Support Center, The University of Tokyo Hospital, Tokyo, Japan.
Ohashi Y; Department of Integrated Science and Engineering, Chuo University, Tokyo, Japan.
Pokaż więcej
Źródło :
Breast cancer research and treatment [Breast Cancer Res Treat] 2019 Aug; Vol. 176 (3), pp. 631-635. Date of Electronic Publication: 2019 May 21.
Typ publikacji :
Journal Article
MeSH Terms :
Patient Participation*
Randomized Controlled Trials as Topic*
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Breast Neoplasms/*drug therapy
Breast Neoplasms/*mortality
Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Biomarkers, Tumor ; Breast Neoplasms/diagnosis ; Bridged-Ring Compounds/administration & dosage ; Combined Modality Therapy ; Drug Combinations ; Female ; Humans ; Kaplan-Meier Estimate ; Middle Aged ; Neoplasm Metastasis ; Neoplasm Staging ; Outcome Assessment, Health Care ; Oxonic Acid/administration & dosage ; Survival Rate ; Taxoids/administration & dosage ; Tegafur/administration & dosage ; Treatment Outcome
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies